2013
DOI: 10.1016/j.radonc.2012.11.012
|View full text |Cite
|
Sign up to set email alerts
|

Evaluation of organ-specific peripheral doses after 2-dimensional, 3-dimensional and hybrid intensity modulated radiation therapy for breast cancer based on Monte Carlo and convolution/superposition algorithms: Implications for secondary cancer risk assessment

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

6
51
0

Year Published

2014
2014
2021
2021

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 56 publications
(57 citation statements)
references
References 71 publications
6
51
0
Order By: Relevance
“…Importantly, the degree to which commercial treatment planning systems underestimate out-of-field dose varies strongly with position and the TPS dose algorithm used. These findings are similar to that which have recently been reported for a number of different TPSs and treatment modalities (Howell et al , 2010; Joosten et al , 2013b; Schneider et al , 2013). The analytical model proposed in this work, on the other hand, continues to predict measured doses at greater accuracy out to a distance of 40 cm from the CAX.…”
Section: Resultssupporting
confidence: 91%
See 1 more Smart Citation
“…Importantly, the degree to which commercial treatment planning systems underestimate out-of-field dose varies strongly with position and the TPS dose algorithm used. These findings are similar to that which have recently been reported for a number of different TPSs and treatment modalities (Howell et al , 2010; Joosten et al , 2013b; Schneider et al , 2013). The analytical model proposed in this work, on the other hand, continues to predict measured doses at greater accuracy out to a distance of 40 cm from the CAX.…”
Section: Resultssupporting
confidence: 91%
“…To our knowledge, no contemporary commercial treatment planning system (TPS) includes the capability to accurately predict stray dose far from the treatment field. Thus, there is a large and systematic underestimation of stray radiation exposures by commonly used clinical TPSs (Howell et al , 2010; Schneider et al , 2014; Joosten et al , 2013a) and as a result, these doses and their effects are not accurately considered during treatment.…”
Section: Introductionmentioning
confidence: 99%
“…Joosten et al [70] partially reported a comparison between TLD measurements in an anthropomorphic phantom and the calculated MC dose. The phantom was irradiated with a five-field technique for prostate cancer.…”
Section: Estimation Of the Dose At The Point Or Volume Of Interestmentioning
confidence: 99%
“…Several papers are published on the evaluation of peripheral and organ doses due to breast cancer radiotherapy; among those the in vivo and phantom measurements using thermo-luminescent dosimeters (TLDs), a computerized Monte Carlo (MC) technique using a mathematical phantom, and several commercial treatment planning software (TPS). [30][31][32][33] Their results vary from method to method, i.e., the peripheral dose difference between TPS and MC was reported up to 70%, 34 while the mean difference between MC out-of-field doses and TLD measurements was found 11.4% ± 5.9%. 30 The percent difference between the TPS and TLD measurement skin doses was found in the range from -15% to 44%.…”
Section: Introductionmentioning
confidence: 99%